Nebulized Ipratropium Bromide-induced Anisocoria: Why Is Anisocoria Observed?
| Autor: | Okşan Derinöz-Güleryüz, Yasemin Men-Atmaca, İlknur Fidanci |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Benign condition
Emergency Medical Services Pediatric emergency medicine Ipratropium bromide medicine Immunology and Allergy Humans Child Asthma Anisocoria business.industry Ipratropium Nebulizers and Vaporizers Disease Management medicine.disease Nebulizer Anesthesia Medicine Disease Susceptibility medicine.symptom Symptom Assessment business medicine.drug |
| Zdroj: | Iranian Journal of Allergy, Asthma and Immunology, Vol 20, Iss 1 (2021) |
| ISSN: | 1735-5249 |
| Popis: | Pharmacological anisocoria is a rare but benign condition. This paper presents an eleven-yearold patient with asthma who developed ipratropium bromide-associated anisocoria during nebulizer treatment. Hypotheses regarding the possible causes of anisocoria are discussed and precautions to be taken during treatment are presented. To prevent the development of anisocoria, it was found that it is important to use the appropriate mask during nebulizer treatment, to place the mask on the face properly, and, if possible, to administer drugs by closing the eyes. Further, it is recommended that patients undergo an ophthalmological examination before discharge and that they and their families be informed that the condition is temporary. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|